ASSESSMENT OF MICROALBUMINURIA IN ESSENTIAL HYPERTENSIVES AND ITS RESPONSE TO ANGIOTENSIN-CONVERTING ENZYME INHIBITOR THERAPY

ABSTRACTObjective: Objective is to study the prevalence of microalbuminuria among patients suffering from essential hypertension and also to evaluate theresponse of microalbuminuria to angiotensin-converting enzyme (ACE) inhibitors therapy.Methods: The study conducted at Santosh Medical College and Hospital, Ghaziabad, on 300 patients with essential hypertension. After attainingbaseline parameters in all patients, those newly diagnosed essential hypertensives with microalbuminuria not on any treatment were started on anACE inhibitor (ramipril), for 8 weeks, after which all parameters were reassessed and comparison and statistical analysis were done to establish theprevalence of microalbuminuria and its response to therapy.Results: In our study, mean microalbuminuria excretion was 101.79 mcg/mg creatinine at the beginning of the study and 80.20 mcg/mg creatinineafter 8 weeks of ACE inhibitor therapy, with 21.2% fall rate.Conclusion: Microalbuminuria is an independent risk factor for the development or worsening of hypertensive nephropathy and endothelialdysfunction, thereby increasing the risk of micro- and macro-vascular complications.Keywords: Microalbuminuria, Essential hypertension, Angiotensin-converting enzyme inhibitor therapy

BIOMARKERS IN SERUM, URIC ACID AS A RISK FACTOR FOR TYPE 2 DIABETES ASSOCIATED WITH HYPERTENSION

ABSTRACTObjectives: Uric acid (UA) is the end product of purine metabolism in humans. UA is the final oxidation product of purine catabolism and has beenimplicated in diabetes mellitus (DM) as well as in hyperlipidemias. Hyperuricemia can cause serious health problems including renal insufficiency.Hyperuricemia is associated with many diseases including hypertension (HTN), DM, hypertriglyceridemia, and obesity. The aim was to determine theserum UA (SUA) level in Patients of Type 2 DM with HTN.Methods: Out of 100 samples, 50 were found as cases of Type 2 diabetic with HTN, and the 50 control samples were without Type 2 diabetic HTN.Results: SUA, glycosylated hemoglobin, and low-density lipoprotein of male and female cases of Type 2 DM with HTN compared to control were(p<0.05) highly significant and also serum triglycerides and total cholesterol of both sex groups of Type 2 DM with HTN compared to control werefound to be (p<0.05) highly significance.Conclusion: It is concluded from our present study that level of SUA >7.0 mg/dl were significantly seen in cases of diabetes with HTN. SUA ≤5.0 mg/dlwas significantly seen in subjects without diabetes with HTN. Our data showed hyperuricemia and glycated hemoglobin as significant risk factors inthe progression of DM, atherosclerosis, myocardial infarction, renal disorder, hypertriglyceridemia, and obesity. Further large sample size studies areneeded to be done in the direction with more focused mechanistic approaches to fortify the fact. Very little is known about the relationship betweenUA, DM, and HTN in India.Keywords: Diabetes mellitus, Hypertension, Uric acid, Glycosylated hemoglobin, Lipid profil